Genetic testing can help identify children at risk of epilepsy, in addition to identifying new genetic mutations associated with the condition. Using CBD based medications can also help reduce seizures in children with epilepsy.
Study reveals a molecular action that enables cilantro to effectively delay seizures. One component of cilantro, dodecenal, binds to a specific part of the potassium channel to open them, reducing cellular excitability.
Seizures associated with Alzheimer's disease in both animal models and humans alter hippocampal neurogenesis. Treating mice with antiseizure medications normalized neurogenesis and improved spatial discrimination.
An observational study reports the use of strobe lighting at concerts and music festivals triples the risk of seizures in those with photosensitive epilepsy. Additionally, the use of ecstasy during nighttime concerts heightened epileptic seizure risk.
Specific transfer RNAs (tRNAs) are associated with epilepsy. The levels of tRNA fragments in blood samples are higher pre-seizure. The findings provide a novel biomarker for the detection of seizures prior to their occurrence.
Results from a phase 3 study reveal Cannabidiol (CBD) cuts seizures by almost 50% in children with Dravet syndrome.
Researchers report EEG technology can help to predict the onset of epileptic seizures up to four minutes in advance. Additionally, acetate, an edible acid, may help to prevent seizures if they are detected with enough notice.
Researchers have developed a new model of mitochondrial epilepsy which captures specific features observed in patients. The new model may help provide better therapies and treatments for the condition.